Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study.
Philipp R AldanaRicardo A HanelJoseph PiattSabrina H HanManisha M BansalCorinna L SchultzCynthia GaugerJohn Michael PedersonJohn C Wellons IiiMonica L HulbertLori C JordanAdnan QureshiKelsey GarrityAdam P RobertAsmaa HatemJennifer SteinEmily BeydlerP David AdelsonStephanie GreenePaul GrabbJames JohnstonShih-Shan LangJeffrey LeonardSuresh N MaggeAlex ScottSanjay ShahEdward R SmithJodi SmithJennifer StrahleSudhakar VadiveluJennifer WebbDavid WrubelPublished in: Pediatric blood & cancer (2023)
When added to conservative management, cerebral revascularization surgery appears to reduce the risk of CVEs in patients with SCD-MMS. A prospective study will be needed to validate these findings.